News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Peptidream Announces The Development Of A New Broad Strain Anti-Influenza Macrocyclic Peptide Therapeutic


4/8/2014 9:34:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TOKYO--(BUSINESS WIRE)--PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)( TOKYO:4587) announced today, in collaboration with The Tokyo Metropolitan Institute of Medical Science (“Tokyo Metropolitan Institute”) the discovery and development of a novel macrocyclic peptide inhibitor for the treatment of multiple influenza strains.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES